Your browser doesn't support javascript.
loading
Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients.
Lino-Silva, Leonardo S; Anchondo-Núñez, Patricia; Chit-Huerta, Alonso; Aguilar-Romero, Estefanía; Morales-Soto, Jonathan; Salazar-García, Jenny A; Guzmán-López, Cristina J; Maldonado-Martínez, Héctor A; Meneses-García, Abelardo; Salcedo-Hernández, Rosa A.
Afiliação
  • Lino-Silva LS; Surgical Pathology, Instituto Nacional de Cancerología, Mexico, Mexico.
  • Anchondo-Núñez P; AFINES Program, Medicine Faculty, Mexico's National Autonomus University, Mexico, Mexico.
  • Chit-Huerta A; Surgical Pathology, Instituto Nacional de Cancerología, Mexico, Mexico.
  • Aguilar-Romero E; AFINES Program, Medicine Faculty, Mexico's National Autonomus University, Mexico, Mexico.
  • Morales-Soto J; AFINES Program, Medicine Faculty, Mexico's National Autonomus University, Mexico, Mexico.
  • Salazar-García JA; AFINES Program, Medicine Faculty, Mexico's National Autonomus University, Mexico, Mexico.
  • Guzmán-López CJ; AFINES Program, Medicine Faculty, Mexico's National Autonomus University, Mexico, Mexico.
  • Maldonado-Martínez HA; Surgical Pathology, Instituto Nacional de Cancerología, Mexico, Mexico.
  • Meneses-García A; Surgical Pathology, Instituto Nacional de Cancerología, Mexico, Mexico.
  • Salcedo-Hernández RA; Surgical Pathology, Instituto Nacional de Cancerología, Mexico, Mexico.
J Surg Oncol ; 120(2): 300-307, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31017669
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Tumor deposits (TDs) are associated with adverse prognostic factors and decreased survival in colorectal cancer. However, controversy exists regarding their definition, evaluation, and staging categories. This study aimed to determine the survival and recurrence impact of the TD in colon adenocarcinomas; and to determine if TD patients behave similarly to stage IV patients.

METHODS:

Cross-section study from 392 patients with colon adenocarcinoma from 2005 to 2012. We performed survival analysis and further stratified patients considering TD patients as a "stage IV-TD" to demonstrate if they behave similarly than stage IV patients.

RESULTS:

From 392 patients, 204 (52%) were men, the mean age was 57.4 ± 13.9 years and 11.5% of cases had TD. In a multivariate analysis, TD failed to predict mortality and recurrence. Considering cases with TD as stage IV-TD, their mean survival was similar to stage IV patients (69.3 and 64.6 months, respectively) and different to those in stage III (110.5 months), II (135.7 months), and I (114.9 months) (P < 0.001).

CONCLUSIONS:

TD failed to predict mortality and recurrence. Patients with TD in stage I-III shows similar mortality than stage IV patients; then, we suggest putting them into a substage IV category instead of the N1c category.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias do Colo / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Surg Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias do Colo / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Surg Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México